Operationalizing Cooperative Research for Infectious Disease Surveillance: Lessons Learned and Ways Forward
Yeh K.B. Parekh F.K. Tabynov K. Tabynov K. Hewson R. Fair J.M. Essbauer S. Hay J.
10 September 2021Frontiers Media S.A.
Frontiers in Public Health
2021#9
The current COVID-19 pandemic demonstrates the need for urgent and on-demand solutions to provide diagnostics, treatment and preventative measures for infectious disease outbreaks. Once solutions are developed, meeting capacities depends on the ability to mitigate technical, logistical and production issues. While it is difficult to predict the next outbreak, augmenting investments in preparedness, such as infectious disease surveillance, is far more effective than mustering last-minute response funds. Bringing research outputs into practice sooner rather than later is part of an agile approach to pivot and deliver solutions. Cooperative multi- country research programs, especially those funded by global biosecurity programs, develop capacity that can be applied to infectious disease surveillance and research that enhances detection, identification, and response to emerging and re-emerging pathogens with epidemic or pandemic potential. Moreover, these programs enhance trust building among partners, which is essential because setting expectation and commitment are required for successful research and training. Measuring research outputs, evaluating outcomes and justifying continual investments are essential but not straightforward. Lessons learned include those related to reducing biological threats and maturing capabilities for national laboratory diagnostics strategy and related health systems. Challenges, such as growing networks, promoting scientific transparency, data and material sharing, sustaining funds and developing research strategies remain to be fully resolved. Here, experiences from several programs highlight successful partnerships that provide ways forward to address the next outbreak. © Copyright
capacity building , Central Asia , cooperative research , COVID-19 , global health security , infectious disease surveillance
Text of the article Перейти на текст статьи
MRIGlobal, Gaithersburg, MD, United States
EpiPointe, LLC, Cary, NC, United States
International Center for Vaccinology, Kazakh National Agrarian Research University, Almaty, Kazakhstan
Public Health England, Salisbury, United Kingdom
School of Hygiene and Tropical Medicine, London, London, United Kingdom
Los Alamos National Laboratory, Los Alamos, NM, United States
Bundeswehr Institute for Microbiology, Munich, Germany
Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, United States
MRIGlobal
EpiPointe
International Center for Vaccinology
Public Health England
School of Hygiene and Tropical Medicine
Los Alamos National Laboratory
Bundeswehr Institute for Microbiology
Jacobs School of Medicine and Biomedical Sciences
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026